[Treatment of acute upper respiratory tract infections in children]

Nevenka Roncević1, Jelena Popadić, Aleksandra Stojadinović

  • 1Institut za zdravstvenu zastitu dece i omladine, Medicinski fakultet, Novi Sad.

Medicinski Pregled
|February 15, 2003
PubMed

Insights

Childhood respiratory infections are common, often viral. Treatment guidelines emphasize individualized antimicrobial therapy based on likely pathogens and patient factors for optimal outcomes.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Context:

  • Acute respiratory tract infections (ARTIs) are the most frequent childhood illnesses, with preschool children experiencing 5-7 upper airway infections annually.
  • Upper airway infections constitute 80-90% of all pediatric respiratory infections.
  • Viral etiology accounts for 75% of ARTIs, with bacterial and other pathogens causing the remainder.

Purpose:

  • To provide evidence-based guidelines for the treatment of pediatric respiratory infections.
  • To outline the principles of antimicrobial therapy selection for respiratory infections in children.
  • To emphasize the importance of individualized treatment strategies in pediatric respiratory care.

Summary:

  • Treatment for respiratory infections involves antimicrobial therapy, symptom relief, and general pediatric care principles.
  • Antimicrobial drug selection depends on pathogen identification, sensitivity, patient age, condition, history, and allergies.
  • Empirical therapy decisions are based on prevalent agents and potential severity when definitive data is unavailable, allowing for later modification.

Impact:

  • Optimizing antimicrobial use in pediatric respiratory infections can reduce morbidity and mortality.
  • Standardized treatment guidelines improve the management of common childhood illnesses.
  • Individualized patient assessment is crucial for effective and safe treatment of respiratory infections in children.
Abstract

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...